Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
| Conditions: | Malignant Mesothelioma |
| Start Date: | February 1, 1999 |
| Phase: | Phase II |
| Status: | Active, not recruiting |
| NCT ID: | NCT00003723 |
| Study Type: | Interventional |
| Intervention: | Drug: cisplatin|Drug: gemcitabine hydrochloride |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Southwest Oncology Group|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 50 |
| Funded By: | Other|NIH |
| First Received: | November 1, 1999 |
| End Date: | |
| Last Updated: | July 23, 2008 |
| Last Verified: | November 1, 2007 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
